4//SEC Filing
Weinberg Uri 4
Accession 0001645113-23-000010
CIK 0001645113other
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 6:24 PM ET
Size
12.5 KB
Accession
0001645113-23-000010
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Weinberg Uri
Chief Innovation Officer
Transactions
- Sale
Ordinary Shares
2023-01-05$120.00/sh−1,201$144,120→ 43,286 total - Sale
Ordinary Shares
2023-01-05$120.00/sh−1,946$233,520→ 47,104 total - Exercise/Conversion
Options to Buy Ordinary Shares
2023-01-05−1,946→ 1,946 totalExercise: $47.04Exp: 2029-03-21→ Ordinary Shares (1,946 underlying) - Exercise/Conversion
Ordinary Shares
2023-01-05$47.04/sh+1,946$91,540→ 49,050 total - Sale
Ordinary Shares
2023-01-05$108.00/sh−2,617$282,636→ 44,487 total - Sale
Ordinary Shares
2023-01-05$120.00/sh−2,379$285,480→ 47,104 total
Footnotes (2)
- [F1]Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Weinberg.
- [F2]Fully vested as of the date hereof.
Documents
Issuer
NovoCure Ltd
CIK 0001645113
Entity typeother
Related Parties
1- filerCIK 0001811030
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 6:24 PM ET
- Size
- 12.5 KB